| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1696028A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/30/2006 | EP1695986A2 Anti-erb B2 antibodies |
| 08/30/2006 | EP1695985A2 Humanized antibodies and methods for forming humanized antibodies |
| 08/30/2006 | EP1695715A1 Vaccine compositions which are used to control amoebiasis and which are based on the 112kda surface protein from entamoeba histolytica |
| 08/30/2006 | EP1695702A2 Treatment of metastatic disease |
| 08/30/2006 | EP1695078A2 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 08/30/2006 | EP1694839A2 Laminin-5 modulators and uses thereof |
| 08/30/2006 | EP1694831A1 Pathogenic bovine enterovirus, vaccines, and diagnostic methods |
| 08/30/2006 | EP1694830A2 Novel atypical pneumonia-causing virus |
| 08/30/2006 | EP1694708A2 Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use |
| 08/30/2006 | EP1694707A1 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 08/30/2006 | EP1694706A2 Modified anti-cd52 antibody |
| 08/30/2006 | EP1694701A2 Pp2a/bgamma subunits, modulators thereof, and their uses in the treatment of mental disorders |
| 08/30/2006 | EP1694700A1 Neutralizable epitope of hgf and neutralizing antibody binding to the same |
| 08/30/2006 | EP1694698A1 Lawsonia intracellularis 26 kd subunit vaccine |
| 08/30/2006 | EP1694697A2 Surface-located campylobacter jejuni polypeptides |
| 08/30/2006 | EP1694364A2 System for treating and preventing breast cancer |
| 08/30/2006 | EP1694360A2 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection |
| 08/30/2006 | EP1694359A2 Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 08/30/2006 | EP1694358A2 Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases |
| 08/30/2006 | EP1694350A1 Use of caspase-8 inhibitors for modulating hematopoiesis |
| 08/30/2006 | EP1694349A2 Integrin alpha ii beta3 specific antibodies and peptides |
| 08/30/2006 | EP1694342A2 Methods of using gelsolin to treat or prevent bacterial sepsis |
| 08/30/2006 | EP1694301A2 Methods and compositions for the production of monoclonal antibodies |
| 08/30/2006 | EP1479773B1 Mite galectin |
| 08/30/2006 | EP1334188B1 Cd19-specific redirected immune cells |
| 08/30/2006 | EP1297011B1 Diagnostic uses of the t-cell protein tzon7, and of the peptides and antibodies derived therefrom |
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1210430B1 Muc-1 derived peptides |
| 08/30/2006 | EP1171604B1 Dna sequence and recombinant production of a graminae allergen |
| 08/30/2006 | EP1015596B1 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 08/30/2006 | EP0980526B1 Inhibitors of nuclear protein/nuclear receptor interaction |
| 08/30/2006 | EP0972036B1 Prion propagation inhibition by dominant-negative prion protein mutants |
| 08/30/2006 | EP0934338B1 Cellular internalization of pigr stalk and associated ligands |
| 08/30/2006 | EP0909316B1 Glial cell line-derived neurotrophic factor receptor |
| 08/30/2006 | EP0796104B1 Delivery of nucleic acid molecules to mucosal tissue |
| 08/30/2006 | EP0728200B1 Haemophilus transferrin receptor genes |
| 08/30/2006 | EP0529033B1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 08/30/2006 | CN1826356A Binding molecules against sars-coronavirus and uses thereof |
| 08/30/2006 | CN1826139A Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 08/30/2006 | CN1826138A Rg1 antibodies and uses thereof |
| 08/30/2006 | CN1826137A Inducible ligand for alpha1beta1 integrin and uses |
| 08/30/2006 | CN1824789A Preparation of testis specific protein 50 monoclonal antibody and polyclonal antibody and use |
| 08/30/2006 | CN1824678A Preparation and use of testes specificity protein 50 human source antibody |
| 08/30/2006 | CN1824675A Neisserial antigens |
| 08/30/2006 | CN1824325A Human nipple virus DNA inserted vaccine, its preparation method and application |
| 08/30/2006 | CN1824308A Therapeutic agent for cachexia |
| 08/30/2006 | CN1824307A Medicinal composition for treating B cell lymph tumour |
| 08/30/2006 | CN1824306A Immunoglobulin-G biofactor chewing gum |
| 08/30/2006 | CN1824305A Preparation method of nano-aluminium adjuvant capable of raising vaccine effect and its use |
| 08/30/2006 | CN1824304A Preparation method of hepatitis vaccine and its use |
| 08/30/2006 | CN1824303A Medicine for treating and/or preventing hepatitis B |
| 08/30/2006 | CN1824302A Preparation method of rabies vaccine for human and its use |
| 08/30/2006 | CN1824291A Hypersensitivity reaction inhibitor |
| 08/30/2006 | CN1823731A Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 08/30/2006 | CN1272436C Synthesis and high-efficiency expression method of bivalent foot-and-mouth disease polypeptide vaccine |
| 08/30/2006 | CN1272435C Gene of Chinese Mainland SjPP gene stock of Japanese blood fluke, clone, expression and application |
| 08/30/2006 | CN1272345C Silensed anti-CD 28 antibodies and use thereof |
| 08/30/2006 | CN1272342C Novel process for preparing recombinaant CHO cell hepatitis B vaccine |
| 08/30/2006 | CN1272070C Poplar bark lipoid adjuvant and its preparing method and using method |
| 08/29/2006 | US7098311 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferative disorders |
| 08/29/2006 | US7098309 Recombinant hepatitis B surface antigen |
| 08/29/2006 | US7098306 Method and compositions for treating hepatocellular cancer |
| 08/29/2006 | US7098303 Immunogenic polypeptide; vaccine for therapy of HCV infection and assays for the diagnosis of HCV |
| 08/29/2006 | US7098184 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 08/29/2006 | US7098183 cell growth differentiation factors/polypeptides for immunization; animal models |
| 08/29/2006 | US7098007 Screening analysis using nucleic acids; antibodies, transgenic animals; antiproliferative agents; induction cell cycle delay |
| 08/29/2006 | US7098006 preparation of an antibody chain having a variable domain comprising three complementarity determining regions |
| 08/29/2006 | US7098004 Isolated polypeptide of the stratum corneum and its use |
| 08/29/2006 | US7097994 UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 08/29/2006 | US7097991 screening for an agent that modulates capsaicin receptor function |
| 08/29/2006 | US7097986 For use in pharmaceutical and diagnostic formulations |
| 08/29/2006 | US7097971 novel peptides based on conserved regions of regulatory and auxiliary HIV proteins, antigens in free or carrier-bound form comprising one of the peptides, vaccine compositions containing one of the antigens, immunoassay kits and a method of detecting antibodies, induced by HIV using such antigens |
| 08/29/2006 | US7097965 Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein |
| 08/29/2006 | US7097846 35 kD tumor associated protein antigen: uses and methods of detection |
| 08/29/2006 | US7097845 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 08/29/2006 | US7097844 T helper cell epitopes |
| 08/29/2006 | US7097843 Immunogenic peptides from the HPV E7 protein |
| 08/29/2006 | US7097842 Modified vaccinia virus ankara for the vaccination of neonates |
| 08/29/2006 | US7097841 Ferritin fusion proteins for use in vaccines and other applications |
| 08/29/2006 | US7097840 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
| 08/29/2006 | US7097839 A conjugated compound contains antibody or a Fab, and a radiostable therapeutic active agent; for diagnosis/therapy of colorectal cancer; biological conjugated drugs |
| 08/29/2006 | US7097838 Antagonists of HMG1 for treating inflammatory conditions |
| 08/29/2006 | US7097837 Synthetic vaccine agents |
| 08/29/2006 | US7097836 Therapeutic treatment of breast tumor with a mixture of chemotherapeutic agent selected from cyclophosphamide or doxorubicin and an antigen binding fragment; synergistic potentiation |
| 08/29/2006 | US7097835 A biological conjugated immunotoxins, comprising a cytotoxin conjugated to an antibody, specifical binding a cell surface-accessible epitope of a vesicular transporter protein; selectively killing, protecting neuronal cell |
| 08/29/2006 | US7097834 Osteoprotegerin binding proteins |
| 08/29/2006 | US7097827 Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments |
| 08/29/2006 | CA2318851C Recombinant human mannan-binding proteins and process for producing the same |
| 08/29/2006 | CA2314934C Use of microparticles combined with submicron oil-in-water emulsions |
| 08/29/2006 | CA2187974C Newcastle disease virus combination vaccine |
| 08/29/2006 | CA2053585C Antibody production in chinese hamster ovary cells |
| 08/24/2006 | WO2006089251A2 SYNERGISTIC EFFECT OF TGF-β BLOCKADE AND IMMUNOGENIC AGENTS ON TUMORS |
| 08/24/2006 | WO2006089218A2 Methods and compositions for modulating angiogenesis |
| 08/24/2006 | WO2006089209A2 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| 08/24/2006 | WO2006089161A2 Immunostimulating polyphosphazene compounds |
| 08/24/2006 | WO2006089133A2 Anti-cd19 antibodies and uses in oncology |
| 08/24/2006 | WO2006089121A2 Streptococcus iniae phosphoglucomutase is a virulence factor and target for vaccine development |